CenterWatch Announces: Data Integrity for GCP Professionals:

CenterWatch Announces: Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges — March. 23 and March. 25, 2021


CenterWatch Announces: Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges — March. 23 and March. 25, 2021
Share Article
Can one’s clinical trials’ data integrity controls withstand FDA scrutiny? Stay compliant and avoid 483s or warning letters. Register today.
WCG CenterWatch
Data Integrity for GCP Professionals:
Core Requirements, Expectations and Challenges
A Virtual Workshop Presented by CenterWatch and Cerulean Associates LLC
Tuesday, March 23 and Thursday, March 25, 2021, 10:00 a.m.-4:30 p.m. EDT
Is the FDA’s increasing scrutiny on clinical trials’ data integrity producing a data migraine? One must establish internal competency and assessment programs; otherwise, one can expect 483s and warning letters to come rolling in.

Related Keywords

John Avellanet , Department Of Justice , European Medicines Agency , Cerulean Associates , Alcoa , Virtual Workshop Presented , Core Requirements , Conference Details , Press Release , துறை ஆஃப் நீதி , சிஇஆர்யுவ்எல்இஏஎன் கூட்டாளிகள் , அல்கோவா , மெய்நிகர் பணிமனை ப்ரெஸெஂடெட் , கோர் தேவைகள் , மாநாடு விவரங்கள் , ப்ரெஸ் வெளியீடு ,

© 2025 Vimarsana